porcin
reproduct
respiratori
syndrom
prr
devast
global
swine
industri
decad
current
strategi
control
prr
inadequ
studi
character
inhibit
prr
viru
prrsv
replic
antisens
phosphorodiamid
morpholino
oligom
pmo
peptideconjug
pmo
ppmo
four
found
highli
effect
inhibit
prrsv
replic
cell
cultur
dosedepend
sequencespecif
manner
ppmo
complementari
sequenc
end
prrsv
genom
sequenc
translat
initi
region
respect
treatment
cell
caus
log
reduct
prrsv
yield
compar
control
ppmo
combin
led
higher
level
reduct
alon
combin
inhibit
prrsv
replic
porcin
alveolar
macrophag
protect
cell
prrsvinduc
cytopath
effect
northern
blot
realtim
rtpcr
result
demonstr
effect
ppmo
led
reduct
prrsv
rna
level
inhibit
viru
replic
strain
prrsv
result
studi
suggest
potenti
applic
ppmo
prr
control
porcin
reproduct
respiratori
syndrom
prr
caus
estim
us
million
loss
per
year
swine
industri
usa
neumann
et
al
clinic
manifest
prr
includ
sever
reproduct
failur
postwean
pneumonia
growth
reduct
increas
mortal
keffab
loula
caus
agent
diseas
prrsv
envelop
singlestrand
positivesens
rna
viru
jj
prrsv
member
famili
arterivirida
includ
equin
arter
viru
eav
lactat
dehydrogenaseelev
viru
year
howev
evid
revers
virul
least
one
current
vaccin
strain
follow
use
pig
opriessnig
et
al
therefor
altern
strategi
need
effect
prr
control
studi
explor
inhibit
prrsv
propag
cell
cultur
peptideconjug
phosphorodiamid
morpholino
oligom
ppmo
specif
prrsv
sequenc
pmo
structur
similar
singlestrand
dna
subunit
includ
purin
pyramidin
base
pmo
base
join
novel
backbon
consist
one
morpholin
ring
phosphorodiamid
linkag
per
subunit
summerton
summerton
weller
pmo
uncharg
watersolubl
highli
resist
nucleas
degrad
hudziak
et
al
pmo
bind
target
mrna
watsoncrick
base
pair
exert
antisens
effect
prevent
access
critic
segment
rna
sequenc
translat
initi
site
steric
blockad
distinctli
differ
process
rnase
hdepend
mechan
induc
oftenus
antisens
structur
type
phosphorothio
dna
summerton
number
studi
shown
pmo
effect
specif
block
translat
target
mrna
vitro
vivo
via
intraven
intraperiton
subcutan
transderm
oral
administr
arora
et
al
b
brent
drapeau
hudziak
et
al
qin
et
al
stein
et
al
taylor
et
al
shown
pmo
conjug
short
argininerich
cell
penetr
peptid
significantli
higher
effici
deliveri
cultur
cell
nonconjug
pmo
moulton
et
al
dea
et
al
ppmo
found
fairli
stabl
cell
human
serum
least
h
youngblood
et
al
sequencespecif
antivir
efficaci
ppmo
cell
cultur
document
sar
coronaviru
neumann
et
al
eav
van
den
born
et
al
flavivirus
dea
et
al
kinney
et
al
influenza
viru
ge
et
al
kaposi
sarcomaassoci
herpesviru
zhang
et
al
recent
ppmo
also
appli
vivo
protect
anim
challeng
ebola
viru
enterlein
et
al
coxsackieviru
yuan
et
al
murin
coronavirus
burrer
et
al
prrsv
rna
genom
approxim
size
consist
untransl
region
utr
nine
open
read
frame
orf
utr
meng
et
al
jj
meulenberg
et
al
two
larg
orf
la
lb
togeth
occupi
kb
encod
nonstructur
protein
like
involv
genom
replic
transcript
jj
remain
orf
encod
six
membraneassoci
protein
e
nucleocapsid
n
protein
meulenberg
et
al
prrsvinfect
cell
set
six
seven
nest
viral
subgenom
rna
form
conzelmann
et
al
jjm
subgenom
rna
ident
leader
sequenc
deriv
end
genom
rna
well
ident
termin
sequenc
preced
poli
tail
variabl
length
gener
cotermin
mrna
speci
believ
accomplish
process
known
discontinu
subgenom
mrna
synthesi
sawicki
sawicki
van
marl
et
al
end
subgenom
mrna
north
american
strain
contain
common
leader
sequenc
base
nelsen
et
al
wherea
lelystad
viru
prototyp
strain
european
prrsv
genotyp
leader
base
jj
utr
north
american
european
prrsv
strain
base
respect
exclud
poli
tail
common
subgenom
mrna
prrsv
subgenom
rna
polycistron
structur
believ
first
open
read
frame
orf
subgenom
rna
translat
viral
protein
meng
et
al
previou
studi
zhang
et
al
test
six
ppmo
found
one
design
target
termin
region
prrsv
genom
highli
effect
inhibitor
prrsv
replic
sequencespecif
dosedepend
manner
consid
lengthi
genom
sequenc
heterogen
prrsv
strain
sought
evalu
ppmo
target
site
genom
broad
reactiv
differ
strain
prrsv
also
refin
evalu
efficaci
ppmo
mechan
action
hope
defin
potenti
strategi
address
prrsv
ppmo
technolog
studi
evalu
dozen
ppmo
target
varieti
differ
site
prrsv
genom
subgenom
negativesens
rna
peptid
compon
ppmo
use
studi
recent
develop
possess
improv
characterist
compar
peptid
use
previou
ppmo
studi
found
possibl
obtain
greaterthanaddit
effect
use
combin
two
ppmo
effect
ppmo
prrsv
rna
synthesi
also
assess
attempt
gain
insight
mechan
ppmomedi
inhibit
prrsv
replic
ppmo
also
shown
studi
inhibit
prrsv
replic
pam
cultur
primari
target
cell
prrsv
infect
pig
cell
line
atcc
meng
et
al
maintain
dmem
medium
supplement
fetal
bovin
serum
fb
prrsv
strain
atcc
meng
et
al
lelystad
jj
nvsl
ame
ia
use
inocul
cell
multipl
infect
moi
ppmo
test
prrsv
strain
use
studi
includ
kindli
provid
dr
fernando
osorio
univers
nebraskalincoln
ingelvac
mlv
kindli
provid
dr
kay
faaberg
univers
minnesota
viru
titrat
seri
dilut
viru
ad
monolay
cell
plate
degre
cytopath
effect
cpe
character
cell
round
clump
detach
assess
microscop
h
prrsv
inocul
comparison
mockinfect
cell
tissu
cultur
infecti
dose
tcid
per
millilit
calcul
base
cpe
develop
accord
method
reed
muench
describ
previous
zhang
et
al
pam
cultur
bronchoalveolar
lavag
collect
week
old
prrsvneg
piglet
describ
previous
shibata
et
al
bronchoalveolar
lavag
fluid
centrifug
g
min
cell
pellet
resuspend
medium
supplement
fb
mm
lglutamin
uml
penicillin
gml
streptomysin
sulfat
gml
gentamycin
cell
plate
densiti
cellswel
cell
cultur
plate
pam
incub
h
c
humidifi
co
incub
wash
plain
media
viru
inocul
ifa
carri
report
previous
zhang
et
al
nspecif
monoclon
antibodi
nvsl
ame
ia
nelson
et
al
specif
reaction
n
protein
detect
goat
antimous
iggfluorescein
isothiocyan
fitc
conjug
sigma
st
loui
mo
observ
fluoresc
microscopi
pam
cell
ifa
perform
fixat
pam
cell
paraformaldehyd
permeabil
triton
follow
incub
antibodi
pmo
synthes
avi
biopharma
inc
corval
method
previous
describ
summerton
weller
peptid
nh
rxr
xbcooh
r
arginin
x
acid
b
coval
conjug
end
pmo
fig
conjug
purif
analysi
ppmo
similar
method
describ
elsewher
abe
et
al
moulton
et
al
random
sequenc
ppmo
name
littl
agreement
prrsv
primat
mrna
sequenc
use
control
nonsequencespecif
activ
ppmo
chemistri
ppmo
dissolv
water
concentr
mm
store
c
experi
ppmo
dilut
desir
concentr
dmem
cell
seed
plate
cell
per
well
grown
overnight
near
confluenc
treatment
cell
conduct
previous
describ
zhang
et
al
briefli
cell
inocul
viru
moi
h
c
inoculum
remov
ppmo
dilut
dmem
ad
cell
incub
h
c
dmem
medium
without
ppmo
includ
mock
treatment
control
ppmo
neg
control
remov
ppmo
mainten
medium
dmem
supplement
fb
ad
cell
incub
h
c
supernat
cell
harvest
analysi
experi
use
ppmo
combin
treatment
two
constitu
ppmo
present
equal
molar
concentr
cross
strain
inhibitori
assay
similar
procedur
describ
use
except
differ
prrsv
strain
use
macrophag
incub
cell
cultur
plate
h
prior
treatment
cell
inocul
prrsv
strain
moi
incub
h
cell
wash
plain
rpmi
medium
addit
ppmo
ppmo
dilut
plain
rpmi
medium
ad
cell
incub
h
c
ppmo
solut
remov
cultur
medium
rpmi
supplement
fb
ad
cell
cultur
observ
cpe
develop
total
rna
isol
prrsvinfect
cell
trizol
reagent
invitrogen
carlsbad
ca
ppmotreat
cell
procedur
grown
cell
cultur
plate
harvest
h
pi
direct
lysi
trizol
reagent
remov
cultur
supernat
cell
treat
mocktreat
includ
control
rna
quantifi
quant
tm
univers
micropl
spectrophotomet
biotek
instrument
winooski
vermont
store
c
analysi
rna
sampl
g
denatur
c
min
immedi
place
ice
min
denatur
rna
separ
v
h
agaros
gel
contain
formaldehyd
separ
rna
transfer
onto
nylon
membran
hybrid
dna
probe
deriv
prrsv
sequenc
pcr
primer
gcgga
tccca
aataa
caccg
gcaag
cgtct
agatg
ccagc
ccatc
atgct
probe
label
pcr
dig
probe
synthesi
kit
roch
diagnost
indianapoli
blot
membran
incub
antidigoxigeninalkalin
phosphat
min
cspd
chemiluminesc
substrat
roch
min
expos
xray
film
quantit
rtpcr
analysi
rna
first
treat
rnasefre
dnase
promega
madison
wi
remov
carryov
dna
rna
isol
procedur
revers
transcript
carri
use
superscript
tm
iii
firststrand
synthesi
system
random
hexam
invitrogen
realtim
pcr
primer
report
previous
zhang
et
al
fragment
base
end
prrsv
genom
clone
vector
use
templat
gener
standard
curv
realtim
pcr
conduct
chromo
tm
fourcolor
realtim
system
biorad
laboratori
hercul
ca
iq
sybr
green
supermix
biorad
transcript
also
amplifi
sampl
order
assur
normal
quantit
rtpcr
detect
prrsv
rna
cell
pair
dna
oligonucleotid
correspond
ppmo
target
sequenc
prrsv
duplex
subclon
upstream
luciferas
code
sequenc
promotercontain
report
plasmid
pcineoluc
describ
previous
zhang
et
al
dna
sequenc
conduct
confirm
presenc
desir
sequenc
result
plasmid
use
neg
control
report
assay
plasmid
dna
linear
downstream
luciferas
sequenc
vitro
transcript
conduct
ribomax
tm
express
larg
scale
rna
product
system
promega
vitro
translat
carri
rabbit
reticulocyt
lysat
translat
system
promega
brightglo
tm
luciferas
assay
system
promega
use
detect
luciferas
yield
luminesc
signal
measur
tm
multilabel
counter
perkinelm
life
analyt
scienc
wellesley
viabil
pam
cell
ppmo
treatment
determin
celltiterglo
luminesc
cell
viabil
assay
promega
briefli
cell
treat
ppmo
condit
similar
describ
ppmo
treatment
cell
mocktreat
cell
includ
comparison
celltiterglo
reagent
ad
incub
min
room
temperatur
luminesc
signal
measur
tm
multilabel
counter
rel
percentag
luminesc
intens
calcul
comparison
mocktreat
control
student
ttest
use
assess
signific
differ
viral
yield
rna
level
group
ppmotreat
cell
twotail
pvalu
less
consid
signific
prrsv
genom
sequenc
retriev
genbank
databas
parallel
sequenc
align
prrsv
strain
two
major
genotyp
show
utr
translat
initi
region
orf
within
genotyp
highli
conserv
region
like
particip
essenti
event
viral
life
cycl
tan
et
al
verheij
et
al
make
ration
site
antisens
ppmo
target
studi
ppmo
design
prrsv
virul
strain
north
american
genotyp
ppmo
sequenc
target
site
locat
prrsv
genom
specifi
tabl
depict
schemat
fig
termin
region
proven
product
ppmo
target
region
number
positivestrand
rna
virus
burrer
et
al
dea
et
al
van
den
born
et
al
zhang
et
al
ppmo
design
basepair
end
region
prrsv
rna
genom
attempt
interfer
translat
viral
rna
replicas
complementari
hairpin
loop
region
predict
secondari
structur
analysi
ppmo
complementari
negativesens
eav
rna
inhibit
eav
replic
cell
cultur
van
den
born
et
al
complementari
end
negativesens
prrsv
rna
design
interfer
product
positivesens
viral
rna
complementari
negativesens
prrsv
rna
transcript
regulatori
sequenc
tr
region
attempt
interfer
synthesi
andor
transla
tion
viral
subgenom
rna
complementari
end
prrsv
rna
genom
attempt
interfer
negativestrand
rna
synthesi
ppmo
complementari
translat
initi
region
orf
respect
attempt
block
translat
orf
ppmo
complementari
nucleotid
prrsv
termin
sequenc
previous
shown
highli
effect
zhang
et
al
includ
posit
neg
control
respect
virul
prrsv
strain
use
evalu
abil
ppmo
inhibit
prrsv
replic
cell
moi
reach
peak
replic
cell
approxim
h
postinocul
initi
experi
ppmo
appli
monolay
cell
final
concentr
dmem
incub
h
immedi
viru
inocul
period
cell
observ
daili
cpe
develop
supernat
collect
day
pi
viru
titrat
cell
determin
prrsv
yield
ppmo
test
found
highli
effect
inhibit
prrsv
cpe
develop
compar
mocktreat
cell
treat
also
show
less
sever
cpe
control
ppmo
effect
prevent
cpe
develop
titrat
prrsv
cell
cultur
supernat
show
treatment
cell
ppmo
caus
log
tcid
reduct
prrsv
yield
comparison
fig
treatment
cell
led
reduct
prrsv
yield
log
tcid
respect
compar
none
ppmo
reduc
prrsv
yield
significantli
ppmo
select
character
studi
confirm
cpe
observ
prrsv
yield
titrat
obtain
ifa
cell
viru
inocul
ppmo
treatment
fig
ifa
use
monoclon
antibodi
prrsv
nprotein
show
treatment
cell
led
absenc
prrsvposit
cell
cell
treat
fluorescentposit
cell
observ
cell
treat
prrsvposit
cell
observ
far
fewer
treat
result
indic
presenc
inhibit
prrsv
replic
cell
ppmo
test
dose
inhibit
replic
cell
fig
littl
effect
viru
replic
comparison
mock
treatment
control
four
antisens
ppmo
reduc
viru
yield
dose
depend
manner
fig
treatment
cell
concentr
led
log
tcid
reduct
prrsv
yield
compar
ppmo
concentr
led
reduct
prrsv
yield
detect
level
assay
assess
cytotox
ppmo
use
studi
cell
viabil
assay
conduct
pam
cell
treat
ppmo
experi
repeat
twice
three
replic
comparison
mock
treatment
control
averag
rel
percentag
cell
viabil
cell
treatment
averag
percentag
viabl
pam
cell
ppmo
treatment
result
viru
titer
shown
tcid
log
ml
mock
sampl
cell
receiv
viru
inocul
ppmo
treatment
statist
signific
differ
viral
yield
ppmo
mock
treatment
p
p
cell
treat
viru
yield
detect
nd
assay
bar
arbitrarili
drawn
show
presenc
sampl
graph
experi
repeat
three
time
error
bar
shown
b
immunofluoresc
assay
monoclon
antibodi
specif
fluoresc
clearli
visibl
h
post
prrsv
infect
fluoresc
observ
uninfect
control
treatment
ppmo
result
reduct
viru
replic
appear
effect
ident
condit
imag
green
fluoresc
imag
taken
dapi
filter
show
total
number
live
cell
demonstr
ppmo
gener
littl
cytotox
pam
cell
indic
suppress
viru
replic
observ
antivir
experi
due
sequencespecif
effect
attempt
deriv
select
index
si
ratio
concentr
drug
caus
cytotox
cc
divid
concentr
drug
caus
inhibit
viral
product
relev
variou
condit
studi
sought
determin
cc
ppmo
cell
treat
h
concentr
ppmo
cell
viabil
determin
h
treatment
period
cc
respect
base
inhibit
viral
product
approxim
fig
dosedepend
inhibit
prrsv
replic
viru
yield
cell
cultur
reduc
concomitantli
increas
concentr
cell
receiv
treatment
viru
yield
detect
nd
assay
bar
arbitrarili
drawn
show
sampl
presenc
graph
dosedepend
inhibit
prrsv
replic
significantli
differ
p
experi
repeat
three
time
error
bar
shown
respect
four
ppmo
fig
conclud
si
antisens
ppmo
condit
investig
effect
treatment
ppmo
combin
prrsv
replic
ppmo
pair
test
equal
molar
concentr
exampl
combin
final
concentr
consist
ppmo
present
ppmo
includ
test
sinc
alreadi
establish
effect
ppmo
target
region
prrsv
thought
involv
transcript
event
test
pair
pair
ppmo
target
translat
initi
region
orf
also
test
result
viru
titrat
show
combin
fig
combinatori
inhibit
assay
ppmo
two
ppmo
ad
equal
molar
concentr
cell
prrsv
inocul
combin
treatment
led
signific
lower
viru
yield
p
either
ppmo
alon
cell
treat
viru
yield
detect
nd
assay
bar
arbitrarili
drawn
show
presenc
sampl
graph
caus
signific
reduct
p
prrsv
yield
comparison
constitu
individu
ppmo
fig
none
ppmo
combin
show
significantli
higher
inhibitori
activ
constitu
individu
ppmo
determin
ppmo
effect
prrsv
rna
synthesi
cell
inocul
treat
ppmo
harvest
h
pi
rna
isol
ppmo
includ
experi
design
block
prrsv
rna
synthesi
combin
ppmo
also
use
see
effect
prrsv
rna
synthesi
ppmo
includ
comparison
northern
blot
analysi
least
seven
distinct
rna
speci
detect
mocktreat
sampl
consist
would
expect
use
probe
detect
indic
prrsv
genom
subgenom
rna
contain
sequenc
detect
rna
seen
treatment
rna
molecular
weight
marker
left
prrsv
rna
transcript
design
indic
right
load
control
transcript
detect
shown
lower
panel
b
quantit
prrsv
rna
realtim
rtpcr
primer
design
amplifi
region
treatment
cell
ppmo
led
signific
reduct
prrsv
genom
rna
level
p
cell
harvest
h
pi
total
rna
isol
realtim
rtpcr
cell
treat
prrsv
rna
detect
nd
assay
bar
arbitrarili
drawn
show
sampl
graph
prrsv
rna
copi
number
sampl
calcul
comparison
standard
curv
normal
transcript
level
see
section
detect
prrsv
rna
sampl
treat
detect
level
fig
ppmo
effect
viral
rna
level
combin
led
signific
reduct
viral
rna
level
fig
ppmo
also
appar
led
modest
reduct
viral
transcript
comparison
northern
blot
show
control
ppmo
produc
small
yet
notic
effect
prrsv
rna
level
compar
mocktreat
howev
slight
nonspecif
inhibit
caus
far
less
high
level
inhibit
produc
sever
antisens
ppmo
realtim
rtpcr
primer
specif
prrsv
also
use
evalu
rna
level
prrsv
genom
rna
could
detect
primer
cell
treat
prrsv
rna
detect
fig
cell
treat
prrsv
genom
rna
reduc
respect
compar
cell
presenc
also
led
reduct
prrsv
genom
rna
comparison
cell
treatment
either
reduc
prrsv
rna
result
consist
northern
blot
analysi
character
sequencespecif
pmomedi
inhibit
prrsv
replic
conduct
cellfre
luciferas
report
assay
target
sequenc
ppmo
subclon
upstream
luciferas
report
express
plasmid
assay
ppmo
bind
rna
target
typic
result
inhibit
translat
downstream
luciferas
code
sequenc
effect
ppmo
treatment
target
rna
translat
assess
measur
luciferas
product
increment
concentr
ppmo
ad
vitro
translat
reaction
determin
ppmo
inhibitori
effect
translat
shown
fig
nm
higher
concentr
reduc
luciferas
yield
littl
effect
translat
correspond
rna
ppmo
slightli
less
effect
three
ppmo
test
result
assay
indic
antisens
ppmo
specif
bound
complementari
rna
therebi
inhibit
translat
luciferas
ppmo
studi
design
strain
prrsv
determin
efficaci
ppmo
eleven
prrsv
strain
mlv
lelystad
cross
strain
inhibit
assay
conduct
lelystad
strain
prototyp
european
genotyp
rest
strain
north
american
prrsv
genotyp
ppmo
combin
test
fig
inhibit
target
rna
translat
ppmo
cellfre
luciferas
report
assay
rel
percentag
luciferas
level
calcul
comparison
signal
control
ppmo
sampl
nm
level
luciferas
product
decreas
respons
increas
concentr
ppmo
littl
effect
luciferas
rna
translat
prrsv
strain
viru
inocul
ppmo
treatment
conduct
manner
describ
viru
titrat
result
show
effect
suppress
replic
strain
except
lelystad
fig
led
notic
reduct
viru
titer
major
north
american
isol
includ
nvsl
mlv
replic
lelystad
inhibit
ppmo
test
sequenc
align
ppmo
target
site
prrsv
strain
show
lelystad
low
sequenc
ident
strain
fig
prrsv
nvsl
one
nucleotid
mismatch
end
target
site
target
site
mismatch
found
nvsl
singl
nucleotid
differ
middl
ppmo
target
region
target
site
nvsl
two
mismatch
lelystad
five
mismatch
two
delet
other
one
mismatch
target
site
one
mismatch
occur
strain
except
lelystad
five
mismatch
sequenc
align
result
indic
nucleotid
mismatch
prrsv
target
site
like
respons
low
level
inhibit
produc
two
ppmo
alveolar
macrophag
primari
target
cell
prrsv
infect
pig
yoon
et
al
evalu
ppmo
effect
viru
replic
pam
relev
biolog
natur
infect
facilit
adapt
laboratori
cultur
pam
cell
preincub
h
inocul
prrsv
viru
inocul
pam
treat
ppmo
observ
h
pi
cpe
develop
pam
treat
fig
cross
strain
inhibit
assay
viru
yield
titrat
show
inhibit
ten
north
american
prrsv
strain
ppmo
lelystad
prototyp
european
prrsv
genotyp
strain
within
north
american
prrsv
genotyp
mock
denot
viru
infect
cell
receiv
ppmo
treatment
cell
ppmo
led
suppress
prrsv
replic
north
american
strain
produc
viru
yield
detect
nd
assay
bar
arbitrarili
drawn
sampl
detect
viru
nd
show
presenc
sampl
graph
b
sequenc
analysi
identifi
nucleotid
mismatch
ppmo
complementari
target
site
prrsv
rna
prrsv
strain
name
list
first
column
sequenc
strain
use
refer
sequenc
ppmo
design
ppmo
name
list
block
prrsv
sequenc
leli
stand
lelystad
strain
littl
similar
utr
strain
indic
symbol
align
target
sequenc
sequenc
nucleotid
differ
refer
sequenc
shown
ident
nucleotid
indic
miss
nucleotid
indic
initi
codon
atg
orf
underlin
genbank
access
number
prrsv
strain
align
list
parenthesi
ppmo
combin
show
littl
cpe
develop
mocktreat
control
cell
suffer
sever
cpe
fig
result
indic
ppmo
treatment
protect
cell
prrsvinduc
cpe
develop
also
prrsv
replic
rapidli
pam
investig
ppmomedi
protect
pam
cpe
develop
treat
pam
twice
h
apart
cpe
observ
cell
day
pi
data
shown
indic
ppmo
treatment
protect
pam
cpe
least
week
prrsv
inocul
ifa
conduct
pam
cell
prrsv
inocul
ppmo
treatment
cell
fix
h
pi
minim
cell
death
mocktreat
control
result
show
approxim
percentag
prrsvposit
cell
treatment
mocktreat
control
fig
result
demonstr
treatment
antisens
ppmo
reduc
prrsv
infect
pam
cell
prrsv
yield
pam
cultur
titrat
cell
treatment
pam
ppmo
led
reduct
viru
yield
respect
compar
mocktreat
control
fig
reduct
viru
titer
pam
consider
less
observ
cell
similar
ppmo
treatment
employ
morpholino
oligom
inhibit
rna
viru
replic
becom
appeal
prospect
report
success
knockdown
cellular
protein
via
inhibit
premrna
splice
andor
translat
mrna
heasman
rna
viru
genom
varieti
region
pmo
target
previou
studi
six
ppmo
design
target
utr
trsregion
genom
rna
end
negativesens
prrsv
rna
evalu
zhang
et
al
one
ppmo
target
termin
region
genom
found
effect
inhibit
prrsv
replic
present
studi
ppmo
design
target
wider
varieti
site
within
prrsv
genom
includ
utr
translat
initi
region
orf
negativesens
prrsv
rna
ppmo
test
found
highli
effect
ppmo
follow
studi
ppmo
appear
effect
previou
studi
zhang
et
al
target
site
locat
termin
region
prrsv
rna
genom
overlap
nucleotid
note
howev
compar
result
two
studi
complic
fact
first
studi
employ
ppmo
peptid
compon
r
f
r
present
studi
util
recent
develop
rxr
peptid
ppmo
complement
hairpin
sequenc
utr
also
quit
effect
reduc
prrsv
yield
log
fig
ppmo
target
correspond
region
eav
likewis
found
highli
effect
van
den
born
et
al
previous
report
combin
pmo
compound
outperform
singl
agent
shown
vivo
nonconjug
pmo
ebola
viru
author
studi
suggest
slow
viru
replic
may
allow
suffici
time
develop
antivir
immun
respons
viral
clearanc
likewis
ge
et
al
show
combin
ppmo
produc
greater
efficaci
either
ppmo
alon
influenza
viru
cell
cultur
ge
et
al
result
show
treatment
combin
led
significantli
higher
prrsv
inhibit
either
two
ppmo
alon
howev
mani
ppmo
combin
studi
fail
outperform
constitu
singl
agent
elucid
mechan
pmomedi
inhibit
conduct
northern
blot
rtpcr
analys
fig
treatment
cell
reduc
prrsv
rna
level
detect
indic
inhibit
prrsv
rna
synthesi
like
accomplish
block
translat
replicas
encod
treatment
combin
also
produc
reduct
prrsv
rna
level
probabl
due
blockag
translat
transcript
orf
base
target
locat
end
prrsv
genom
specul
combin
may
reduc
prrsv
genom
replic
interf
assembl
progress
replicas
complex
result
clearli
show
reduct
prrsv
rna
level
cell
treat
ppmoassoci
reduct
prrsv
rna
product
also
observ
rtpcr
previou
studi
zhang
et
al
convers
similar
experi
eav
show
signific
chang
level
viral
rna
transcript
assess
gel
hybrid
analysi
van
den
born
et
al
seem
discrep
may
result
differ
experiment
condit
rna
isol
cell
harvest
h
pi
prrsv
h
eav
experi
van
den
born
et
al
like
differ
replic
mechan
prrsv
eav
sinc
ppmo
design
target
respect
trsregion
report
effect
eav
van
den
born
et
al
yet
ineffect
prrsv
zhang
et
al
among
ppmo
test
studi
found
significantli
efficaci
reason
ineffect
ppmo
unclear
could
includ
inaccess
prrsv
target
sequenc
success
ppmotarget
rna
duplex
affect
prrsv
replic
ppmo
combin
effect
inhibit
prrsvinduc
cpe
develop
primari
pam
major
target
cell
type
prrsv
infect
host
anim
ifa
confirm
ppmo
inhibit
viru
replic
result
indic
ppmo
may
inde
potenti
control
reduc
sever
prrsv
infect
pig
unexpect
ppmomedi
reduct
viru
yield
pam
less
observ
cell
differ
may
prrsv
higher
replic
rate
pam
cell
ppmo
unabl
significantli
interfer
rapid
viral
replic
altern
differenti
uptak
ppmo
pam
cultur
may
effect
howev
viru
replic
pam
treatment
result
cytopath
effect
cell
healthi
least
week
viru
inocul
studi
undertaken
investig
ppmomedi
protect
primari
cell
ppmo
inhibit
replic
ten
north
american
prrsv
strain
crossstrain
inhibit
assay
sequenc
align
fig
show
region
target
ppmo
contain
highli
conserv
sequenc
addit
analysi
prrsv
sequenc
genbank
indic
complementari
sequenc
highli
conserv
across
north
american
prrsv
strain
thu
two
antisens
ppmo
may
suitabl
applic
north
american
prrsv
strain
broad
inhibit
also
confirm
utr
prrsv
highli
product
target
region
ppmo
region
like
play
import
role
arteriviru
replic
one
base
mismatch
ppmo
respect
target
site
ten
north
american
prrsv
strain
may
explain
low
activ
observ
fig
b
noteworthi
strain
ident
sequenc
target
site
thu
minor
sequenc
modif
ppmo
target
region
may
lead
improv
efficaci
cell
viabil
assay
ppmotreat
cell
pam
detect
cytotox
indic
suppress
prrsv
replic
observ
antivir
assay
due
ppmospecif
inhibit
prrsv
molecular
event
absenc
ppmoinduc
cytotox
effect
antivir
concentr
import
attribut
compound
consid
potenti
vivo
applic
preval
prrsv
financi
loss
associ
prrsv
infect
swine
herd
high
current
strategi
control
prr
includ
use
commerci
autogen
vaccin
inconsist
gener
less
adequ
meng
opriessnig
et
al
specif
antiprrsv
drug
would
use
complement
strategi
prrsv
prevent
control
condit
studi
four
ppmo
show
potent
specif
antiprrsv
activ
cell
cultur
consid
potenti
drug
candid
use
prrsv
control
investig
pharmacokinet
toxicolog
antivir
properti
ppmo
vivo
warrant
